1. Hovstadius B, Hovstadius K, Astrand B, Petersson G: Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol. 2010, 10: 16-10.1186/1472-6904-10-16.
2. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K: High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011, 342: d3514-10.1136/bmj.d3514.
3. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM: Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008, 168: 1890-1896.
4. Wennberg D, Siegel M, Darin B, Filipova N, Russell R, Kenney L, Steinort K, Park T-R, Cakmakci G, Dixon J, Curry N, Billings J: Combined predictive model: Final report and technical documentation. 2006, London: Department of Health, New York University, The King’s Fund, Health Dialogue
5. Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO: Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol. 2014, In press. DOI: 10.1111/bcp.12292